You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2025

Suppliers and packagers for proventil-hfa


✉ Email this page to a colleague

« Back to Dashboard


proventil-hfa

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Kindeva PROVENTIL-HFA albuterol sulfate AEROSOL, METERED;INHALATION 020503 NDA AUTHORIZED GENERIC Sandoz Inc 0781-7296-85 1 CANISTER in 1 CARTON (0781-7296-85) / 200 AEROSOL, METERED in 1 CANISTER 2021-03-15
Kindeva PROVENTIL-HFA albuterol sulfate AEROSOL, METERED;INHALATION 020503 NDA AUTHORIZED GENERIC Praxis, LLC 59368-412-01 1 CANISTER in 1 CARTON (59368-412-01) / 200 AEROSOL, METERED in 1 CANISTER 2021-03-15
Kindeva PROVENTIL-HFA albuterol sulfate AEROSOL, METERED;INHALATION 020503 NDA AUTHORIZED GENERIC Preferred Pharmaceuticals Inc. 68788-7996-2 1 CANISTER in 1 CARTON (68788-7996-2) / 200 AEROSOL, METERED in 1 CANISTER 2021-08-10
Kindeva PROVENTIL-HFA albuterol sulfate AEROSOL, METERED;INHALATION 020503 NDA AUTHORIZED GENERIC REMEDYREPACK INC. 70518-4528-0 1 CANISTER in 1 CARTON (70518-4528-0) / 200 AEROSOL, METERED in 1 CANISTER 2025-12-03
Kindeva PROVENTIL-HFA albuterol sulfate AEROSOL, METERED;INHALATION 020503 NDA AUTHORIZED GENERIC Bryant Ranch Prepack 72162-1212-2 1 CANISTER in 1 CARTON (72162-1212-2) / 200 AEROSOL, METERED in 1 CANISTER 2021-03-15
Kindeva PROVENTIL-HFA albuterol sulfate AEROSOL, METERED;INHALATION 020503 NDA AUTHORIZED GENERIC Proficient Rx LP 82804-036-67 1 CANISTER in 1 CARTON (82804-036-67) / 200 AEROSOL, METERED in 1 CANISTER 2021-03-15
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Last updated: August 2, 2025

ppliers for the Pharmaceutical Drug: Proventil-HFA

Introduction to Proventil-HFA

Proventil-HFA, marketed under the generic name albuterol sulfate, is a bronchodilator primarily used to treat or prevent bronchospasm in conditions such as asthma, chronic obstructive pulmonary disease (COPD), and other respiratory disorders. It is delivered via inhalation, with the inhaler containing hydrofluoroalkane (HFA) as a propellant, thus its brand manufacturing name “Proventil-HFA.” As a widely prescribed medication, securing reliable suppliers is critical for manufacturers, healthcare providers, and distribution channels to meet global demand while maintaining high-quality standards.

Key Components and Manufacturing Origins

The active pharmaceutical ingredient (API) albuterol sulfate is synthesized through complex chemical processes requiring high purity standards, often supplied by specialized chemical manufacturers. The HFA propellant, primarily 1,1,1,2-tetrafluoroethane, is produced by chemical multinationals with expertise in fluorinated compounds.

API Suppliers:
Major API producers for albuterol sulfate plants are located primarily in North America, Europe, and Asia, including firms such as Teva Pharmaceutical Industries, Sun Pharmaceutical Industries, and Lupin. These companies often operate under stringent Good Manufacturing Practice (GMP) certifications to ensure pharmaceutical-grade API quality.

HFA Propellant Suppliers:
The HFA propellant is supplied by chemical giants like Honeywell and Chemours, specialized in fluorochemicals with global manufacturing facilities. These companies supply HFA to inhaler manufacturers worldwide, compliant with environmental and safety standards.

Leading Suppliers in the Industry

1. API Suppliers

  • Teva Pharmaceutical Industries Ltd.
    As one of the largest generic drug manufacturers globally, Teva produces albuterol sulfate API used both for generic inhalers and different formulations. Their extensive manufacturing facilities ensure consistent supply and quality control.
  • Sun Pharmaceutical Industries Ltd.
    Based in India, Sun Pharma is a key API supplier, producing albuterol sulfate for various inhaled medications. Their global footprint enables widespread distribution to meet international demand.
  • Lupin Limited
    Also headquartered in India, Lupin supplies high-quality albuterol sulfate APIs, adhering to international regulatory standards, particularly for markets in Asia, Africa, and Latin America.
  • Farmaceutica Saúde (Brazil)
    Regional supplier with localized production capabilities, primarily serving Latin American markets with GMP-compliant APIs.

2. HFA Propellant Suppliers

  • Honeywell International Inc.
    As a leading fluorochemicals producer, Honeywell supplies HFA-134a through its global manufacturing sites, ensuring consistent quality and regulatory compliance for inhaler manufacturers.
  • Chemours Company
    A key producer of fluorochemicals, Chemours supplies HFA propellants with a focus on environmental standards, including compliance with regulations like the Montreal Protocol.

Supplier Selection Considerations

Selection of suppliers for Proventil-HFA involves strict criteria:

  • Regulatory compliance: Suppliers must demonstrate adherence to GMP, ISO standards, and environmental regulations.
  • Quality assurance: Certificates of analysis (CoA), batch records, and drug master files (DMF) are necessary to validate API and propellant quality.
  • Supply reliability: Ability to meet global demand, scalability, and contingency plans for disruptions.
  • Cost efficiency: Competitive pricing without compromising quality.
  • Environmental responsibility: Particularly relevant for HFA propellants, where suppliers must meet international environmental standards.

Emerging Trends and Market Dynamics

The global demand for inhalers like Proventil-HFA continues to grow, driven by rising respiratory disease prevalence. Manufacturers are increasingly engaging multiple suppliers to mitigate risks associated with supply chain disruptions, especially given the environmental pressures and regulations surrounding fluorinated gases. Recent investments in sustainable HFA production methods and the expansion of API manufacturing capacity in India and China reflect industry trend shifts.

Supply Chain Challenges and Opportunities

  • Regulatory hurdles: Variations in national registration processes can delay approval and supply.
  • Environmental regulations: Phasing out of certain HFA gases may necessitate sourcing from compliant suppliers or transitioning to alternative propellants.
  • Quality consistency: Maintaining batch-to-batch uniformity is critical, requiring suppliers with robust GMP compliance.
  • Strategic partnerships: Long-term collaborations with credible suppliers can secure priority access and favorable terms.

Conclusion

The supply landscape for Proventil-HFA involves a complex network of reputable API manufacturers and fluorochemical companies. Geographic diversity, stringent regulatory oversight, and technological advancements shape the procurement strategies of pharmaceutical companies. Establishing strong relationships with trusted suppliers such as Teva, Sun Pharma, Lupin, Honeywell, and Chemours ensures supply stability for this essential inhaler medication amid evolving global demands and environmental considerations.


Key Takeaways

  • Core suppliers for Proventil-HFA include API producers like Teva, Sun Pharma, Lupin, and fluorochemical firms such as Honeywell and Chemours.
  • Regulatory compliance, quality assurance, and environmental standards are critical factors in supplier selection.
  • Diversifying suppliers mitigates risks linked to regulatory changes, environmental reforms, and supply disruptions.
  • The industry is witnessing a push toward more sustainable HFA production methods in response to environmental regulations.
  • Strategic supplier partnerships are essential to ensure reliable supply chains, especially during increasing global demand.

FAQs

1. Who are the primary API suppliers for albuterol sulfate used in Proventil-HFA?
Major API suppliers include Teva Pharmaceutical Industries, Sun Pharma, Lupin, and regional players, all of which manufacture GMP-compliant albuterol sulfate for inhalation products.

2. Which companies supply the HFA propellant for Proventil-HFA inhalers?
Honeywell and Chemours are the leading suppliers of HFA-134a, the propellant used in Proventil-HFA inhalers, providing high-quality, environmentally compliant fluorochemicals.

3. What criteria are used to select suppliers for Proventil-HFA?
Suppliers are evaluated based on regulatory compliance, quality assurance, production capacity, environmental standards, and cost competitiveness.

4. How is the supply chain affected by environmental regulations regarding HFA gases?
Regulations like the Montreal Protocol are phasing out certain HFA gases, prompting manufacturers to source from suppliers compliant with newer standards and invest in alternative, environmentally friendly formulations.

5. What are the emerging trends in the supply of Proventil-HFA?
Industry trends include increasing capacity in Asia, adoption of sustainable HFA production methods, and strengthened supplier partnerships to address growing global demand and regulatory complexities.

Sources
[1] U.S. Food and Drug Administration (FDA), Inhalation Drug Products, https://www.fda.gov/
[2] IQVIA Institute for Human Data Science, Global Trends in Respiratory Drugs, 2022.
[3] Chemours Official Website, Fluorochemicals and HFA Propellants, https://www.chemours.com.
[4] Honeywell International Inc., HFA Propellants Overview, https://www.honeywell.com.
[5] Teva Pharmaceutical Industries, Corporate Reports, https://www.tevapharm.com.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.